← Leaderboards
Erik Faber
University Of Minnesota
$144,021
Attributed
$144,021
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.5K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$144,021 · 1
By mechanism
F30$144,021 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Nicholas Mark Levinson$8,462,997
- Daniel A Harki$4,359,886
- Naoko Shima$3,634,819
- Haojie Huang$10,928,769
- Carol Ann Lange$17,870,830
Others in their field
Other Emerging Leaders on “Active Sites”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Martha Hering · Westat, Inc.$57,098,843
- Susan Abushakra · Alzheon, Inc.$50,765,244
Research focus
Active SitesAdverse EventAffinityAllosteric SiteAnalogAnti-CancerBindingBinding SitesBiological ModelsBiological ProcessBiological TestingBiologyCancer CellCancer Cell LineCareerCcne1 GeneCdk2 GeneCell CycleCell ModelCell ProliferationCellsChemical StructureChronic Myeloid LeukemiaAcids
Grant awards (3)
Development of Allosteric Inhibitors against Cyclin-Dependent Kinase 2 (Cdk2)$48,519
F30 · FY2021 · CA · contact PI
Development of Allosteric Inhibitors against Cyclin-Dependent Kinase 2 (Cdk2)$48,003
F30 · FY2020 · CA · contact PI
Development of Allosteric Inhibitors against Cyclin-Dependent Kinase 2 (Cdk2)$47,499
F30 · FY2019 · CA · contact PI